Our study, involving a relatively large sample size and various experimental techniques, found that VEGFA and its main receptor, VEGFR2, were markedly upregulated in CE patients, implying that CE may be associated with excessive endometrial angiogenesis. The gene discussed is VEGFA; the disease is cholesteryl ester measurement.